Journal profile · Urology & Nephrology
Aging Male
ISSN 1368-5538 · eISSN 1473-0790 · Taylor and Francis Ltd. · ENGLAND · Quarterly · Founded 1998
Aging Male: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 2.96; JCR Q2 (journal website); fully open access; APC about USD 2,630; median 94 days to acceptance (98 articles, last 24 months); community-reported acceptance: fairly easy; 57 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Aging Male is published by Taylor and Francis Ltd. and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Hormonal and reproductive studies, Sexual function and dysfunction studies and Urinary Bladder and Prostate Research, together about 47.5% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The Aging Male , the official journal of the International Society for the Study of the Aging Male, is a multidisciplinary publication covering all aspects of male health throughout the aging process. The Journal is a well-recognized and respected resource for anyone interested in keeping up to date with developments in this field. It is published in one volume per year. The Journal publishes original peer-reviewed research papers as well as review papers and other appropriate educational material that provide researchers with an integrated perspective on this new, emerging specialty. Areas of interest include, but are not limited to: Diagnosis and treatment of late-onset hypogonadism Metabolic syndrome and related conditions Treatment of erectile dysfunction and related disorders Prostate cancer and benign prostate hyperplasia The Editor welcomes submissions from members of the International Society for the Study of the Aging Male and also from non-members anywhere in the world. The Journal uses single anonymized peer review. *Please note that The Aging Male converted to a fully Open Access journal beginning with Volume 24 (2020). The 1997-2020 volumes are now free to access. Please note, the Print ISSN is not in active use as this journal is no longer published in print.
From the journal's Aims & Scope
Research area (LetPub): Urology & Nephrology
Editor-in-chief Michael ZitzmannPublisher website
Editorial board by country: 1 in mainland China (about 25%); most named Mainland China 1, Germany 1, Israel 1, Russia 1 (4 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Hormonal and reproductive studiesMedicine25.4%
- Sexual function and dysfunction studiesMedicine13.6%
- Urinary Bladder and Prostate ResearchMedicine8.5%
- Prostate Cancer Diagnosis and TreatmentMedicine6.3%
- Sexual Differentiation and DisordersBiochemistry, Genetics and Molecular Biology4.7%
- Pharmacology and Obesity TreatmentMedicine4.2%
- Prostate Cancer Treatment and ResearchMedicine4.1%
- Muscle metabolism and nutritionBiochemistry, Genetics and Molecular Biology3.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
| Minor | Urology & Nephrology | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
| Minor | Urology & Nephrology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Endocrinology & Metabolism | Zone 4 |
| Minor | Urology & Nephrology | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- JCR Q2 · best quartile · 2025
- CiteScore Q2 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCurrent ContentsPublisher website
Other: Index Medicus
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.96LetPub ·
- Impact factor (publisher) 2025
- 3Publisher website ·
- 5-year impact factor (publisher) 2025
- 2.3Publisher website ·
- CiteScore 2026-06
- 3.9LetPub ·
- CiteScore (publisher) 2025
- 3.9Publisher website ·
- SJR 2026-06
- 0.58LetPub ·
- SJR (publisher) 2025
- 0.58Publisher website ·
- SNIP 2026-06
- 0.82LetPub ·
- SNIP (publisher) 2025
- 0.82Publisher website ·
- h-index
- 41LetPub ·
- h-index
- 65OpenAlex ·
- i10-index
- 646OpenAlex ·
- 2-year mean citedness
- 2.41OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 54LetPub ·
- Downloads per year (publisher)
- 518,000Publisher website ·
Articles by year OpenAlex count · 1,373 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 48 | 48 | 18 |
| 2025 | 57 | 57 | 128 |
| 2024 | 40 | 40 | 204 |
| 2023 | 39 | 39 | 395 |
| 2022 | 35 | 35 | 345 |
| 2021 | 21 | 21 | 243 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
94 daysMedian, submission to acceptance · P25–P75 49 days – 185 days
- Acceptance to online
- median 10 days (99 articles)
- Submission to online
- median 106 days
- Sample
- 98 articles with submission and acceptance dates (117 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Submission to publication (journal-reported)
- about 6 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | AUD 3,655 / EUR 2,520 / GBP 2,100 / USD 2,630 | No | CC BY, CC BY-NC | |
| OpenAlex | GBP 2,085 | — | — | |
| Publisher website | Yes, amount not published | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access
- Open access Open access
The Aging Male is an open access journal and only publishes open access articles. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the discoverability and readership of your article Make an impact and reach new readers, not just those with eas…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Taylor and Francis Ltd.
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Quarterly
- Founded
- 1998
- ISSN
- 1368-5538
- Electronic ISSN
- 1473-0790
- Society / sponsor
- International Society for the Study of the Aging Male
- Latest issue on the website
- Volume 29, Issue 1 (2026)
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- APC information ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about Aging Male
What CAS zone is Aging Male in?
In the 2025 upgraded edition of the CAS Journal Ranking, Aging Male is in Zone 3 of Medicine, and in Zone 3 of the minor category Endocrinology & Metabolism / Urology & Nephrology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Aging Male?
The latest impact factor listed by LetPub is 2.96; CiteScore 3.9, h-index 65.
How long does peer review take at Aging Male?
Based on the dates recorded on 98 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 94 days (interquartile range 49–185 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Aging Male in?
The journal's website gives JCR Q2 (best quartile). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 3 of Medicine.
Where are the editorial board members of Aging Male based?
Of the 4 board members whose country the journal's board page names, 1 (about 25%) are in mainland China; the countries named most often are Mainland China (1), Germany (1) and Israel (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Aging Male?
According to LetPub and DOAJ records, Aging Male is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, Embase and Current Contents; that list has not been checked against each database.
Is Aging Male open access, and what is the APC?
Aging Male is a fully open-access journal. APC about USD 2,630.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .